Advertisement
Research Article

No Evidence for XMRV in German CFS and MS Patients with Fatigue Despite the Ability of the Virus to Infect Human Blood Cells In Vitro

  • Oliver Hohn,

    Affiliations: Centre for Biological Security 4, Robert Koch-Institute, Berlin, Germany, Centre for Retrovirology, Robert Koch-Institute, Berlin, Germany

    X
  • Kristin Strohschein,

    Affiliation: Institute for Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany

    X
  • Alexander U. Brandt,

    Affiliation: NeuroCure Clinical Research Center (NCRC), Charité Universitätsmedizin Berlin, Berlin, Germany

    X
  • Sandra Seeher,

    Affiliation: Centre for Biological Security 4, Robert Koch-Institute, Berlin, Germany

    X
  • Sandra Klein,

    Affiliation: Centre for Biological Security 4, Robert Koch-Institute, Berlin, Germany

    X
  • Reinhard Kurth,

    Affiliation: Robert Koch-Institute, Berlin, Germany

    X
  • Friedemann Paul,

    Affiliation: NeuroCure Clinical Research Center (NCRC), Charité Universitätsmedizin Berlin, Berlin, Germany

    X
  • Christian Meisel,

    Affiliation: Institute for Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany

    X
  • Carmen Scheibenbogen equal contributor,

    equal contributor Contributed equally to this work with: Carmen Scheibenbogen, Norbert Bannert

    Affiliation: Institute for Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany

    X
  • Norbert Bannert equal contributor mail

    equal contributor Contributed equally to this work with: Carmen Scheibenbogen, Norbert Bannert

    bannertn@rki.de

    Affiliations: Centre for Biological Security 4, Robert Koch-Institute, Berlin, Germany, Centre for Retrovirology, Robert Koch-Institute, Berlin, Germany

    X
  • Published: December 22, 2010
  • DOI: 10.1371/journal.pone.0015632

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.